Stenocoat Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Secondary Activities: Pharmaceutical Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Engineering Services | Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services

Full name: Stenocoat Sp. z o.o.

Profile Updated: April 10, 2025

Stenocoat Sp. z o.o. is a company in Poland, with a head office in Warsaw. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The enterprise was incorporated on January 23, 2020. A growth of 62.65% was recorded in its total assets.

Headquarters
Ul. Symboliczna 3/92
Warsaw; Mazowieckie; Postal Code: 01-252

Contact Details: Purchase the Stenocoat Sp. z o.o. report to view the information.

Website: http://www.stenocoat.com

Basic Information

Registered Capital:

Purchase the Stenocoat Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Stenocoat Sp. z o.o. report to view the information.

Incorporation Date:

January 23, 2020

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Stenocoat Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating Profit

N/A

Net Profit/Loss for the Period

N/A

Total Assets

62.65%▲

Total Equity

41.63%▲

Return on Equity (ROE)

N/A

Similar companies